AtriCure (ATRC) Tops Q4 EPS by 9c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $34.80 +1.52%
Revenue Growth %: +11.6%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
CCEL, MHGU, PLG, More
Revenue Growth %: +11.6%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.09), $0.09 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $88 million versus the consensus estimate of $87.77 million.
GUIDANCE:
AtriCure sees FY2023 revenue of $380-387 million, versus the consensus of $381.7 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- DHT Holdings Q2 TCE earnings estimated at $126,700 per day
- Disney initiated at Buy as analyst sees parks, streaming fueling next growth phase
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
